Filtered By:
Condition: Sarcoidosis
Procedure: Transplants

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Invasive Hemodynamics and Rejection Rates in Patients With Cardiac Sarcoidosis After Heart Transplantation
ConclusionsPatients with CS have similar post-transplant hemodynamics as patients without CS, without evidence of right ventricular dysfunction or pulmonary hypertension. Neither significant rejection nor recurrence of sarcoid in the allograft was observed in this cohort of patients with CS. Survival is similar between patients with CS and those without CS. Heart transplant is a viable strategy in selected patients with CS with excellent outcomes.RésuméIntroductionLa transplantation cardiaque orthotopique (TCO) est de plus en plus utilisée lors d’insuffisance cardiaque terminale liée à une sarcoïdose cardiaque (SC)...
Source: Canadian Journal of Cardiology - July 24, 2018 Category: Cardiology Source Type: research

Invasive Hemodynamics and Rejection Rates in Patients with Cardiac Sarcoidosis After Heart Transplantation
Conclusions CS patients have similar post-transplant hemodynamics as non-CS patients, without evidence of RV dysfunction or pulmonary hypertension. No significant rejection nor recurrence of sarcoid in the allograft were observed in this cohort of patients with CS. Survival is similar between CS and non-CS patients. Heart transplant is a viable strategy in selected CS patients with excellent outcomes. Teaser Orthotopic heart transplant (OHT) is utilized for end-stage heart failure due to cardiac sarcoidosis (CS). There is a lack of data on long-term outcomes. We explored changes in hemodynamics, allograft rejection and sur...
Source: Canadian Journal of Cardiology - April 7, 2018 Category: Cardiology Source Type: research

A one-year longitudinal evaluation of cerebrospinal fluid and blood neurochemical markers in a patient with cryptococcal meningitis complicated by ischemic stroke.
Cryptococcal meningitis (CCM) is caused by the encapsulated basidiomycetous yeast Cryptococcus neoformans and is one of the most common central nervous system (CNS) infections in immunocompromised subjects [1 –4]. In this regard, autoimmune diseases, sarcoidosis, glucocorticoid treatment, solid-organ transplantation, hematologic malignancies, diabetes mellitus, chronic renal failure are well-known predisposing factors for CCM in HIV-negative patients [1–4]. Sources of C. neoformans are excrement of b irds such as pigeons, contaminated soil, and the bark of several tree species [1].
Source: Journal of the Neurological Sciences - December 13, 2021 Category: Neurology Authors: Samir Abu-Rumeileh, Tamara Garibashvili, J ürgen Benjamin Hagemann, Veronika Still, Franziska Bachhuber, Markus Otto, Hayrettin Tumani, Makbule Senel Tags: Letter to the Editor Source Type: research